Tag: microbion
Trial results show three-fold reduction in diabetic foot ulcer size with...
Microbion Corporation has announced results from a Phase 1b trial of its microbial bioenergetic inhibitor, pravibismane, in patients with moderate to severe infected diabetic foot ulcers...